In a significant leadership move, the global consumer healthcare company Haleon has announced the appointment of a new President for its India and Subcontinent operations. This strategic decision underscores the region's critical importance to the company's global growth ambitions.
A New Leader at the Helm
Sushobhan Dasgupta has been named as the new President for Haleon's business across India and the Subcontinent. He steps into this pivotal role with immediate effect, taking over the reins from Anurita Chopra, who led the market for the past three years. Dasgupta's appointment is a key part of Haleon's strategy to strengthen its leadership in one of the world's most dynamic consumer healthcare markets.
Dasgupta is not a newcomer to the Haleon ecosystem or the fast-moving consumer goods (FMCG) sector. He brings with him a wealth of experience, having spent over two decades at GlaxoSmithKline Consumer Healthcare, which later demerged to become Haleon. His most recent position was serving as the General Manager for Haleon's operations in Malaysia and Singapore, where he was responsible for steering the business and building strong brands.
Strategic Focus for the Indian Market
The India and Subcontinent region represents a major growth engine for Haleon. The company boasts a powerful portfolio of trusted consumer health brands in the country, including household names like Panadol, Sensodyne, Polident, Otrivin, and Centrum. Under the new leadership, the focus is expected to remain on driving innovation, expanding reach, and deepening consumer connections.
In his new capacity, Sushobhan Dasgupta will be tasked with overseeing the entire commercial strategy for the region. His mandate will include:
- Driving sustainable growth and market share for Haleon's portfolio.
- Leading the team to enhance consumer-centric innovation.
- Strengthening digital and omnichannel presence in a rapidly evolving market.
- Building on the strong legacy of trusted health brands in the region.
Dasgupta's deep understanding of the Haleon business, combined with his experience in Asian markets, positions him well to navigate the unique opportunities and challenges in India and the neighbouring Subcontinent nations.
Building on a Strong Foundation
The outgoing President, Anurita Chopra, is credited with solidifying Haleon's market position during her tenure. She is now set to take on a global role within Haleon's Oral Health category, indicating internal recognition of her successful leadership in India. This transition reflects Haleon's practice of nurturing and moving talent across its global operations.
The leadership change comes at a time when the consumer health awareness in India is at an all-time high. The market is witnessing increased demand for over-the-counter wellness products, vitamins, and oral care solutions. Haleon, with its science-backed portfolio, is poised to capitalize on this trend. The company's strategy likely involves not just urban centers but also a deeper penetration into tier-2 and tier-3 cities, where health consciousness is growing rapidly.
Industry observers see this appointment as a clear signal of Haleon's long-term commitment to the Indian subcontinent. By placing an experienced insider like Dasgupta in charge, the company aims to ensure continuity while injecting fresh strategic perspective to capture the next phase of growth. The move is expected to bring stability and focused ambition to Haleon's operations in this crucial region.
